Novel Oxygenation Indices in Robot-Assisted Laparoscopic Surgeries

September 1, 2024 updated by: Furkan Tontu, Başakşehir Çam & Sakura City Hospital

How Do Novel Oxygenation Indices Change with Trendelenburg Position in Robot-Assisted Laparoscopic Surgeries?

In this study, changes in new oxygenation indices investigated by Asar et al. will be compared with conventional oxygenation and saturation indices in patients undergoing robot-assisted laparoscopic surgery due to pneumoperitoneum and Trendelenburg position.

Study Overview

Detailed Description

During the intraoperative period, optimal oxygenation should be achieved while avoiding the harmful effects of hypoxia and hyperoxia in patients. The PaO2/FiO2 and SpO2/FiO2 ratios have been traditionally used to assess this condition. Subsequently, oxygenation indices incorporating mean airway pressure have been developed, such as the oxygenation index (OI = (FiO2 × Pmean) / PaO2) and oxygenation saturation index (OSI = (FiO2 × Pmean) / SpO2). More recently, Asar et al. have defined 8 novel oxygenation indices using mean power (MP) and driving pressure (DP) instead of Pmean (OSI-MPtot, OI-MPtot, OSI-ΔPinsp, OI-ΔPinsp, OSI-MPdyn, OI-MPdyn, PaO2/(FiO2xPEEP), and SpO2/FiO2xPEEP). They compared the predictive power of these new indices for intensive care unit (ICU) mortality in COVID-ARDS (C-ARDS) patients with conventional oxygenation indices (PaO2/FiO2, SpO2/FiO2, OI, OSI). OI-ΔPinsp, OSI-ΔPinsp, and OSI-MPdyn indices were found to have the highest predictive power for ICU mortality. However, there is currently no study investigating the changes of these new indices during the intraoperative period.

Study Type

Observational

Enrollment (Actual)

56

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Basaksehir Cam Sakura City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Study Population The study will include 42 volunteer patients, aged over 18, classified under the American Society of Anesthesiologists Physical Status Classification (ASA) I-III risk groups, who are scheduled to undergo robot-assisted laparoscopic surgery at the Health Sciences University Basaksehir Cam and Sakura City Hospital operating room.

Description

Inclusion Criteria:

  • ASA (American Society of Anesthesiologists) class I-III
  • Age between 18-75 years
  • Signed informed consent form

Exclusion Criteria:

  • Diagnosis of COPD (Chronic Obstructive Pulmonary Disease) and asthma
  • History of thoracic surgery
  • Body mass index (BMI) > 35
  • Development of hemodynamic instability or desaturation (SpO2 < 92) during the operation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients undergoing robotic-assisted laparoscopic surgery
The patients consist of ASA I-II or III group undergoing robotic-assisted laparoscopic surgery.
Arterial blood gas was obtained immediately after intubation(Tint) in supine position. Ventilator parameters and hemodynamic parameters were recorded.
Arterial blood gas was obtained immediately after pneumoperitoneum in trendelenburg position. Ventilator parameters and hemodynamic parameters were recorded.
Arterial blood gas was obtained immediately after pneumoperitoneum in trendelenburg position. Ventilator parameters and hemodynamic parameters were recorded.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum OSI-MPtot in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on OI-MPtot in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on OSI-ΔPinsp in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on OI-ΔPinsp in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on OSI-MPdyn in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on OI-MPdyn in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on PaO2/(FiO2xPEEP) in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on SpO2/FiO2xPEEP in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on SpO2/FiO2 in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on OI (oxygenation index) in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Oxygenation indices
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
This study aims to investigate the effects of Trendelenburg position and pneumoperitoneum on OSI (oxygenation saturation index) in ASA I-III patients undergoing robot-assisted laparoscopic surgery.
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mechanical ventilator parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in PEEP (cmH2O) with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Mechanical ventilator parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in compliance (mL/cmH2O) with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Mechanical ventilator parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in peak pressure (cmH2O) with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Arterial blood gas parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in the pH with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Arterial blood gas parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in the base excess(mmol/lt) with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Arterial blood gas parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in the partial oxgyen(mmHg) with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Arterial blood gas parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in the partial carbon dioxide(mmHg) with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Arterial blood gas parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in the lactate(mmol/lt) with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Hemodynamic parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in the heart rate with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Hemodynamic parameters
Time Frame: during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)
Change in the mean arterial blood pressure with Trendelenburg position and pneumoperitoneum
during the surgery and immediately after the surgery (approximately 3 hours to 6 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Actual)

August 1, 2024

Study Completion (Actual)

August 30, 2024

Study Registration Dates

First Submitted

May 15, 2024

First Submitted That Met QC Criteria

May 21, 2024

First Posted (Actual)

May 28, 2024

Study Record Updates

Last Update Posted (Estimated)

September 5, 2024

Last Update Submitted That Met QC Criteria

September 1, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Not decided yet

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilator-Induced Lung Injury

Clinical Trials on Tint Time

Subscribe